Trust Co. of Vermont Invests $1.68 Million in Intuitive Surgical, Inc. $ISRG

Key Points

• Trust Co. of Vermont purchased a new $1.68 million stake in Intuitive Surgical during the second quarter, buying 4,224 shares. Institutional investors and hedge funds collectively own 83.64% of the company.
• Intuitive Surgical insiders sold 17,070 shares worth approximately $6.93 million over the past 90 days, including director sales executed under pre-arranged Rule 10b5-1 plans.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $508.68. The company recently exceeded quarterly EPS and revenue expectations, reporting $2.80 EPS and $2.89 billion in revenue, up 18.4% year over year.

Trust Co. of Vermont purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 4,224 shares of the medical equipment provider's stock, valued at approximately $1,680,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Main Street Group LTD acquired a new position in Intuitive Surgical during the 1st quarter valued at about $30,000. Laurel Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $31,000. Vermillion Wealth Management Inc. raised its stake in shares of Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider's stock worth $31,000 after buying an additional 25 shares during the last quarter. Turning Point Benefit Group Inc. lifted its holdings in Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider's stock valued at $32,000 after buying an additional 50 shares during the period. Finally, Motiv8 Investments LLC bought a new position in Intuitive Surgical in the fourth quarter valued at approximately $34,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other news, Director Gary S. Guthart sold 10,000 shares of the stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total value of $4,000,000.00. Following the transaction, the director directly owned 1,245,679 shares of the company's stock, valued at $498,271,600. This represents a 0.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 400 shares of the firm's stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the sale, the director owned 251 shares of the company's stock, valued at approximately $95,129. This represents a 61.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 17,070 shares of company stock valued at $6,933,986 in the last ninety days. Company insiders own 0.60% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. BNP Paribas Exane upgraded Intuitive Surgical to an "outperform" rating in a report on Tuesday, July 28th. JPMorgan Chase & Co. cut their price target on shares of Intuitive Surgical from $550.00 to $450.00 and set an "overweight" rating on the stock in a research report on Friday, July 17th. BTIG Research reduced their price objective on shares of Intuitive Surgical from $512.00 to $469.00 and set a "buy" rating on the stock in a research note on Friday, July 17th. BMO Capital Markets restated an "outperform" rating on shares of Intuitive Surgical in a report on Monday, July 20th. Finally, Bank of America lowered their target price on shares of Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average price target of $508.68.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $391.18 on Wednesday. The company's 50-day moving average price is $390.17 and its two-hundred day moving average price is $438.79. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The stock has a market capitalization of $138.20 billion, a PE ratio of 44.81, a price-to-earnings-growth ratio of 2.85 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The company had revenue of $2.89 billion for the quarter, compared to analysts' expectations of $2.83 billion. During the same quarter in the prior year, the business posted $1.81 EPS. The business's revenue was up 18.4% compared to the same quarter last year. On average, analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source